NCT05982561View on ClinicalTrials.gov

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions

Bladder Cancer

Trial Locations (3)

46202

RECRUITING

Indiana University School of Medicine, Indianapolis

63130

RECRUITING

Washington University, St Louis

72211

RECRUITING

Arkansas Urology Research Center, Little Rock

Sponsors

Lead Sponsor

Early is Good Inc.

All Listed Sponsors

lead

Early is Good Inc.

INDUSTRY

NCT05982561 - Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter